<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="790" width="595">
	<fontspec id="0" size="10" family="KCOLOH+FbgmccAdvTT43ccf47d" color="#000000"/>
	<fontspec id="1" size="10" family="KCOLPH+BdtydlAdvTT5fa5645c.I" color="#000000"/>
	<fontspec id="2" size="10" family="KCOLOH+FbgmccAdvTT43ccf47d" color="#131413"/>
	<fontspec id="3" size="10" family="KCOLPI+SyhfjvAdvTT43ccf47d+20" color="#000000"/>
	<fontspec id="4" size="9" family="KCOEIO+RdhjypAdvTT99c4c969" color="#131413"/>
	<fontspec id="5" size="10" family="KCOEIP+DgnmqfAdvTT86d47313" color="#131413"/>
	<fontspec id="6" size="8" family="KCOEBM+FsqmqlAdvTTaf7f9f4f.B" color="#131413"/>
	<fontspec id="7" size="8" family="KCOEHM+SgntnfAdvTTb5929f4c" color="#131413"/>
	<fontspec id="8" size="8" family="KCOEGL+VkmbcqAdvTTe45e47d2" color="#131413"/>
	<fontspec id="9" size="8" family="KCOFHM+VvxtfgAdvTT7329fd89.I" color="#131413"/>
	<fontspec id="10" size="8" family="MyriadPro" color="#131413"/>
<text top="88" left="65" width="9" height="9" font="0">(i)</text>
<text top="88" left="76" width="121" height="9" font="1">Deep brain stimulation (DBS).</text>
<text top="88" left="201" width="82" height="9" font="0">Several basal ganglia</text>
<text top="100" left="76" width="188" height="9" font="0">nuclei become inactive or dysfunctional in PD.</text>
<text top="112" left="76" width="212" height="9" font="0">Surgical implantation of very fine electrodes in these</text>
<text top="124" left="76" width="213" height="9" font="0">areas can be used to keep them functionally active, a</text>
<text top="136" left="76" width="197" height="9" font="0">process called deep brain stimulation (DBS). The</text>
<text top="148" left="76" width="208" height="9" font="0">thalamus, globus pallidus interna (Gpi), or STN are</text>
<text top="160" left="76" width="96" height="9" font="0">target regions for DBS [</text>
<text top="160" left="173" width="14" height="9" font="2"><a href="">182</a></text>
<text top="160" left="187" width="92" height="9" font="0">], where the electrodes</text>
<text top="172" left="76" width="188" height="9" font="0">are implanted, in one or both the hemispheres</text>
<text top="184" left="76" width="17" height="9" font="0">(Fig.</text>
<text top="184" left="97" width="10" height="9" font="2"><a href="">14</a></text>
<text top="184" left="106" width="5" height="9" font="0">).</text>
<text top="196" left="76" width="193" height="9" font="0">In DBS, devices containing two batteries, which</text>
<text top="208" left="76" width="174" height="9" font="0">generate finely tuned electrical currents for</text>
<text top="220" left="76" width="209" height="9" font="0">stimulating those deep brain areas, are implanted in</text>
<text top="232" left="76" width="201" height="9" font="0">both sides in the chest under the collar bone. The</text>
<text top="244" left="76" width="196" height="9" font="0">electrical pulses are generated by these batteries,</text>
<text top="256" left="76" width="199" height="9" font="0">which can be programmed precisely according to</text>
<text top="268" left="76" width="166" height="9" font="0">the specific needs of the PD patient. At 3</text>
<text top="266" left="243" width="6" height="13" font="3">–</text>
<text top="268" left="248" width="24" height="9" font="0">5 year</text>
<text top="266" left="273" width="2" height="13" font="3">’</text>
<text top="280" left="76" width="208" height="9" font="0">intervals, the implanted batteries can be checked or</text>
<text top="292" left="76" width="197" height="9" font="0">replaced or recharged, accordingly. The DBS can</text>
<text top="304" left="76" width="204" height="9" font="0">reduce many primary motor symptoms of PD, and</text>
<text top="316" left="76" width="211" height="9" font="0">also decrease the need for L-DOPA to reduce dyski-</text>
<text top="328" left="76" width="30" height="9" font="0">nesias <a href="">[</a></text>
<text top="328" left="106" width="14" height="9" font="2"><a href="">183</a></text>
<text top="328" left="121" width="163" height="9" font="0"><a href="">]. </a>In addition, the electrodes can be pro-</text>
<text top="340" left="76" width="213" height="9" font="0">grammed to be turned on or off, as needed, by using</text>
<text top="352" left="76" width="82" height="9" font="0">a hand-held device <a href="">[</a></text>
<text top="352" left="158" width="14" height="9" font="2"><a href="">184</a></text>
<text top="352" left="173" width="113" height="9" font="0"><a href="">]. </a>However, the greatest dis-</text>
<text top="364" left="76" width="203" height="9" font="0">advantage of using DBS, is that it requires surgical</text>
<text top="376" left="76" width="206" height="9" font="0">implantation of the device, which can cause poten-</text>
<text top="388" left="76" width="206" height="9" font="0">tial complications, including stroke or hemorrhage,</text>
<text top="400" left="76" width="213" height="9" font="0">risk of infection, speech, or balance problems. More-</text>
<text top="412" left="76" width="112" height="9" font="0">over, DBS is not effective in</text>
<text top="410" left="191" width="3" height="13" font="3">“</text>
<text top="412" left="194" width="30" height="9" font="0">atypical</text>
<text top="410" left="225" width="3" height="13" font="3">”</text>
<text top="412" left="231" width="52" height="9" font="0">parkinsonian</text>
<text top="424" left="76" width="180" height="9" font="0">syndromes, such as multiple system atrophy,</text>
<text top="436" left="76" width="198" height="9" font="0">progressive supra-nuclear palsy, or posttraumatic</text>
<text top="88" left="324" width="60" height="9" font="0">parkinsonism <a href="">[</a></text>
<text top="88" left="384" width="14" height="9" font="2"><a href="">184</a></text>
<text top="88" left="399" width="133" height="9" font="0"><a href="">]. </a>In addition, DBS is not used to</text>
<text top="100" left="324" width="208" height="9" font="0">treat the early stages or for treating mild symptoms</text>
<text top="112" left="324" width="212" height="9" font="0">of PD, or not suitable for treating the cognitive, psy-</text>
<text top="124" left="324" width="193" height="9" font="0">chological, or any other non-motor symptoms <a href="">[</a></text>
<text top="124" left="517" width="14" height="9" font="2"><a href="">183</a></text>
<text top="124" left="532" width="5" height="9" font="0"><a href="">].</a></text>
<text top="136" left="313" width="11" height="9" font="0">(ii)</text>
<text top="136" left="324" width="125" height="9" font="1">Pallidotomy and thalamotomy.</text>
<text top="136" left="452" width="65" height="9" font="0">The parts of the</text>
<text top="148" left="324" width="187" height="9" font="0">brain which control our voluntary movements</text>
<text top="160" left="324" width="191" height="9" font="0">include the globus pallidus (GP), a part of basal</text>
<text top="172" left="324" width="178" height="9" font="0">ganglia which has strong connections to the</text>
<text top="184" left="324" width="188" height="9" font="0">striatum and the thalamus. In pallidotomy, the</text>
<text top="196" left="324" width="179" height="9" font="0">surgeon selectively destroys a part of the GP</text>
<text top="208" left="324" width="17" height="9" font="0">(Fig.</text>
<text top="208" left="345" width="10" height="9" font="2"><a href="">15</a></text>
<text top="208" left="354" width="173" height="9" font="0">). Therefore, the synaptic connections with</text>
<text top="220" left="324" width="194" height="9" font="0">thalamus or striatum are altered in a way which</text>
<text top="232" left="324" width="208" height="9" font="0">decreases tremor, rigidity, bradykinesia, and posture</text>
<text top="244" left="324" width="121" height="9" font="0">abnormalities in PD patients <a href="">[</a></text>
<text top="244" left="445" width="14" height="9" font="2"><a href="">185</a></text>
<text top="244" left="460" width="5" height="9" font="0"><a href="">].</a></text>
<text top="256" left="324" width="211" height="9" font="0">This surgical method can also reduce the amount of</text>
<text top="268" left="324" width="198" height="9" font="0">L-DOPA that the PD patient requires, which can</text>
<text top="280" left="324" width="191" height="9" font="0">decrease drug-induced dyskinesia and dystonia.</text>
<text top="292" left="324" width="194" height="9" font="0">Similarly, destruction of the thalamus, known as</text>
<text top="304" left="324" width="214" height="9" font="0">thalamotomy, can interrupt the connections between</text>
<text top="316" left="324" width="211" height="9" font="0">the basal ganglia and motor cortex, in ways that can</text>
<text top="328" left="324" width="194" height="9" font="0">restore neurotransmitter balance (e.g. glutamate</text>
<text top="340" left="324" width="200" height="9" font="0">excitation) and reduce symptoms, such as tremor</text>
<text top="352" left="324" width="3" height="9" font="0">[</text>
<text top="352" left="328" width="14" height="9" font="2"><a href="">185</a></text>
<text top="352" left="342" width="186" height="9" font="0"><a href="">]. </a>Thalamotomy is used mainly for controlling</text>
<text top="364" left="324" width="206" height="9" font="0">tremor, and it is not very effective for bradykinesia,</text>
<text top="376" left="324" width="109" height="9" font="0">rigidity, or dyskinesias (Fig.</text>
<text top="376" left="436" width="10" height="9" font="2"><a href="">15</a></text>
<text top="376" left="446" width="5" height="9" font="0"><a href="">).</a></text>
<text top="401" left="305" width="112" height="8" font="4">Cell transplantation therapy</text>
<text top="412" left="305" width="234" height="9" font="5">Transplantation of neuronal stem cells into the brains</text>
<text top="424" left="305" width="234" height="9" font="5">of PD patients is considered to be one of the most</text>
<text top="436" left="305" width="234" height="9" font="5">promising approaches for treating this disease <a href="">[186].</a></text>
<text top="699" left="63" width="24" height="7" font="6">Fig. 14</text>
<text top="699" left="89" width="439" height="7" font="7">Schematic diagram show the process of DBS. In DBS, STN or thalamus or the globus pallidus interna (Gpi) (in this case STN) are stimulated by</text>
<text top="709" left="63" width="464" height="7" font="7">an implanted apparatus contains batteries that produce electrical stimulation (like a pace-maker). Stimulating the STN can activate the GPi, which can</text>
<text top="719" left="63" width="453" height="7" font="7">strongly inhibit the thalamus (right side circuitry) which can activate the motor cortex; in turn, allowing more control into the movement of limbs</text>
<text top="33" left="57" width="16" height="7" font="8">Maiti</text>
<text top="33" left="76" width="125" height="7" font="9">et al. Translational Neurodegeneration</text>
<text top="32" left="203" width="40" height="9" font="10"> (2017) 6:28 </text>
<text top="33" left="492" width="47" height="7" font="8">Page 21 of 35</text>
</page>
</pdf2xml>
